Live from the NIH registry
Studies recruiting near Fredericksburg right now
Top 25 of 33 recruiting studies, sorted by proximity — each links to its official registry page
A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma
Neoplasms, Head and Neck
Phase 3
Interventional 864 participants sought
GSK Investigational Site — Fredericksburg, Virginia (1.5 mi)
· Sponsor: GlaxoSmithKline
Product Surveillance Registry
Cardiac Rhythm Disorders, Urological Disorders
N/A
Observational 100,000 participants sought
Research site — Fredericksburg, Virginia (1.5 mi)
· Sponsor: Medtronic
A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitecan-hziy Versus Standard of Care in the Treatment of Advanced Urothelial Cancer
Locally Advanced Urothelial Carcinoma, Metastatic Urothelial Carcinoma
Phase 3
Interventional 320 participants sought
Hematology Oncology Associates of Fredericksburg Inc — Fredericksburg, Virginia (1.5 mi)
· Sponsor: National Cancer Institute (NCI)
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8
Phase 2
Interventional 56 participants sought
Kaiser Permanente-Caton Hill Medical Center — Woodbridge, Virginia (27.9 mi)
· Sponsor: SWOG Cancer Research Network
E-Mindfulness Approaches for Living After Breast Cancer
Breast Cancer, Depression
Phase 3
Interventional 402 participants sought
Kaiser Permanente-Caton Hill Medical Center — Woodbridge, Virginia (27.9 mi)
· Sponsor: NRG Oncology
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8
Phase 2
Interventional 66 participants sought
Kaiser Permanente-Caton Hill Medical Center — Woodbridge, Virginia (27.9 mi)
· Sponsor: SWOG Cancer Research Network
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Breast Cancer
Phase 3
Interventional 3,960 participants sought
Hematology Oncology Associates of Fredericksburg Inc — Fredericksburg, Virginia (1.5 mi)
· Sponsor: NRG Oncology
Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer
Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction , or Esophageal Adenocarcinoma, Metastatic Gastric Cancer
Phase 2, Phase 3
Interventional 840 participants sought
Virginia Cancer Specialists, PC — Woodbridge, Virginia (27.9 mi)
· Sponsor: Pfizer
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Breast Carcinoma, Colorectal Carcinoma
N/A
Observational 2,000 participants sought
Hematology Oncology Associates of Fredericksburg Inc — Fredericksburg, Virginia (1.5 mi)
· Sponsor: Wake Forest University Health Sciences
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8
Phase 3
Interventional 306 participants sought
Hematology Oncology Associates of Fredericksburg Inc — Fredericksburg, Virginia (1.5 mi)
· Sponsor: National Cancer Institute (NCI)
Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer
Extensive-stage Small-cell Lung Cancer
Phase 3
Interventional 621 participants sought
Hematology Oncology Associates of Fredericksburg, Inc. — Fredericksburg, Virginia (1.5 mi)
· Sponsor: BioNTech SE
INHANCE Stemless Reverse Shoulder IDE
Arthroplasty, Replacement
N/A
Interventional 168 participants sought
Mary Washington Orthopedics in affiliation with FOA — Fredericksburg, Virginia (1.5 mi)
· Sponsor: DePuy Orthopaedics
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
Elevated Lp(a), Atherosclerotic Cardiovascular Disease (ASCVD)
Phase 3
Interventional 10,450 participants sought
Mary Washington Hospital — Fredericksburg, Virginia (1.5 mi)
· Sponsor: Eli Lilly and Company
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
Anatomic Stage II Breast Cancer AJCC v8, Early Stage Triple-Negative Breast Carcinoma
Phase 3
Interventional 1,295 participants sought
Kaiser Permanente-Caton Hill Medical Center — Woodbridge, Virginia (27.9 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Cognitive Training for Cancer Related Cognitive Impairment in Breast Cancer Survivors
Breast Cancer, Cognitive Impairments
N/A
Interventional 386 participants sought
Kaiser Permanente-Caton Hill Medical Center — Woodbridge, Virginia (27.9 mi)
· Sponsor: NRG Oncology
A Phase IIb Study to Evaluate the Effect of Dapagliflozin in Combination With Baxdrostat Compared With Baxdrostat on Albuminuria in Participants With Chronic Kidney Disease and High Blood Pressure.
Chronic Kidney Disease and Hypertension
Phase 2
Interventional 218 participants sought
Research Site — Woodbridge, Virginia (27.9 mi)
· Sponsor: AstraZeneca
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
Chronic Kidney Disease and Hypertension
Phase 3
Interventional 5,000 participants sought
Research Site — Woodbridge, Virginia (27.9 mi)
· Sponsor: AstraZeneca
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum
N/A
Interventional 9,500 participants sought
Kaiser Permanente-Caton Hill Medical Center — Woodbridge, Virginia (27.9 mi)
· Sponsor: NRG Oncology
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Triple-Negative Breast Cancer
Phase 3
Interventional 1,530 participants sought
Mary Washington Hospital ( Site 0129) — Fredericksburg, Virginia (1.5 mi)
· Sponsor: Merck Sharp & Dohme LLC
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
Atrial Fibrillation (AF)
Phase 3
Interventional 2,500 participants sought
Anthos Investigational site 9817 — Fredericksburg, Virginia (1.5 mi)
· Sponsor: Anthos Therapeutics, Inc.
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
Breast Cancer, Metastatic Breast Cancer
Phase 3
Interventional 404 participants sought
Hematology-Oncology Associates of Fredericksburg, Inc — Fredericksburg, Virginia (1.5 mi)
· Sponsor: BriaCell Therapeutics Corporation
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
CRC (Colorectal Cancer)
Phase 3
Interventional 700 participants sought
Mary Washington Healthcare — Fredericksburg, Virginia (1.5 mi)
· Sponsor: Incyte Corporation
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS
Acute Coronary Syndrome
Phase 3
Interventional 2,000 participants sought
Research Site — Fredericksburg, Virginia (1.5 mi)
· Sponsor: DalCor Pharmaceuticals
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
Non-small Cell Lung Cancer
Phase 3
Interventional 1,160 participants sought
Research Site — Fredericksburg, Virginia (1.5 mi)
· Sponsor: AstraZeneca
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8
Phase 2, Phase 3
Interventional 378 participants sought
Kaiser Permanente-Caton Hill Medical Center — Woodbridge, Virginia (27.9 mi)
· Sponsor: SWOG Cancer Research Network